Abstract：Objective To observe the clinical efficacy of Edaravone combined with Shuxuening Injection in treatment of Acute Cerebral Infarction. Methods From January 2013 to February 2016, seventy-seven patients with acute ischemic stroke treated in Changping District Hospital of Traditional Chinese Medicine were selected, according to their visit sequences, they were randomly divided into treatment group (n=39) and control group (n=38). Patients in the control group were treated with Shuxuening Injection on the basis of regular treatment, and patients in the treatment group were treated with Edaravone combined with Shuxuening Injection. The neurologic impairment and effects after treatment were observed and compared. Results The defectiveness ratings of nervous functions, the assessment of self-care ability, and the efficacy of the treatment group were noticeably higher than those of control group, the differences were statistically significant (P < 0.05). Compared with before treatment, the plasma viscosity and total blood viscosity of the control group decreased significantly after treatment, and the difference was statistically significant (P < 0.05). There was no significant change in plasma viscosity and total blood viscosity in treatment group before and after treatment (P > 0.05). There was no adverse effect in both groups. Conclusion Shuxuening Injection combined with Edaravone has a significant clinical effect in treating acute cerebral infarction, which can effectively improve nervous function of the patients and their self-care ability.
杨丽. 依达拉奉联合舒血宁注射液治疗急性脑梗死的效果[J]. 中国医药导报, 2018, 15(11): 74-77.
YANG Li. Clinical study on combining Edaravone with Shuxuening Injection in treatment of patients with acute cerebral infarction. 中国医药导报, 2018, 15(11): 74-77.
2018, Vol. 15 
京公网安备 11010502046598号